STAT3 inhibitor. Inhibits binding of tyrosine-phosphorylated peptides to STAT3 SH2 domain and inhibiting STAT3 activation, dimerization and nuclear translocation. Displays selectivity over STAT1, STAT5, c-Myc/Max, Jun/Jun and Lck. Induces apoptosis in STAT3-dependent cancer cell lines. Alkyates...
Know who made it. See the evidence. Buy through one marketplace.
STAT3 inhibitor. Inhibits binding of tyrosine-phosphorylated peptides to STAT3 SH2 domain and inhibiting STAT3 activation, dimerization and nuclear translocation. Displays selectivity over STAT1, STAT5, c-Myc/Max, Jun/Jun and Lck. Induces apoptosis in STAT3-dependent cancer cell lines. Alkyates four cysteine residues on STAT3. Exhibits potent antitumor activity. Protects against angiotensin II-induced vascular dysfunction and hypertension. An extremely useful tool to probe involvement of STAT3 in cellular signaling
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
STAT3 identifies signal transducer and activator of transcription 3 in Homo sapiens (Human). This target record connects NCBI Gene 6774, UniProtKB P40763 and related ABMIUM catalogue products.
Biological function: STAT3 is a signal transducer and transcription factor activated downstream of multiple cytokine and growth-factor receptors. Following phosphorylation and dimerisation, STAT3 can translocate to the nucleus and regulate gene expression controlling processes including proliferation, survival, differentiation and immune responses.
